Skip to main content
. Author manuscript; available in PMC: 2014 Feb 28.
Published in final edited form as: Psychiatry Res. 2012 Nov 15;211(2):112–118. doi: 10.1016/j.pscychresns.2012.07.008

Table 3.

Post-hoc tests examining the above 3×2×3 interactions

Region Side Post Hoc test Condition t df P F
Caudate L ATT>HC CD3 3.48 27 0.002 11.98
NAT>HC CD3 2.09 26 0.047 4.34
Middle Temporal Gyrus (BA39) L NAT>ATT AB1 2.87 28 0.008 8.18
NAT>ATT AB3 2.36 28 0.026 5.53
NAT>ATT CD2 2.78 28 0.010 7.66
ATT>HC CD3 2.39 27 0.025 5.67
NAT>HC AB1 2.69 26 0.013 7.17
NAT>HC AB3 2.35 26 0.027 5.48
NAT>HC CD2 3.23 26 0.003 10.35
NAT>HC CD3 2.58 26 0.016 6.61
Hippocampus L NAT>ATT CD2 2.96 28 0.006 8.72
ATT>HC AB2 2.20 27 0.037 4.84
ATT>HC CD3 2.76 27 0.010 7.57
NAT>HC AB1 2.32 26 0.029 5.35
NAT>HC AB2 3.13 26 0.004 9.69
NAT>HC AB3 2.56 26 0.017 6.53
NAT>HC CD2 4.05 26 0.0004 16.25
NAT>HC CD3 3.31 26 0.003 10.84
Medial Frontal Gyrus (BA10) R NAT>ATT AB3 2. 27 28 0.031 5.14
ATT>HC CD1 2.35 27 0.027 5.48
NAT>HC AB3 3.14 26 0.004 9.79
Thalamus R NAT>ATT AB3 3. 61 28 0.001 12.93
NAT>HC AB3 2.32 26 0.029 5.35
Fusiform Gyrus (BA37) L ATT>HC CD3 2.52 27 0.018 6.33
Occipital Gyrus (BA19) R HC>ATT CD2 2.43 27 0.022 5.88

For Condition, AB=high risk, CD=low risk, Numeral=block (e.g. AB=high risk choices in block 1)